Less than a year after Rhopressa launch, Aerie scores new glaucoma drug approval
Just over a year after securing approval for its glaucoma drug, Rhopressa, Aerie Pharmaceuticals has followed up with an approval for its second such …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
